ACTITHERA NORWAY AS
Developing precision radioligand therapies to treat difficult cancer cases.
Oversigt
- 10
- Medarbejdere
- Ukendt
- Omsætning
- 2025
- Grundlagt
Nøglebeslutningstagere
John Crowley
Independent Director
Igor Mochalkin
Vice President of Discovery Technologies
Libuse Tauchmanova
Vice President of Global Clinical Development
Paul Scola
Senior Vice President of Chemistry
+10 flere kontakter i Funnelfeedr
Beskrivelse
Actithera is a biotechnology company founded in 2021 that focuses on developing next-generation radioligand therapies for cancer treatment. Their proprietary chemistry platform is designed to maximize radiation delivery to tumors while minimizing exposure to healthy tissues. By utilizing covalent ch...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- Aksjeselskap
- Momsnummer
- Ukendt
Beslutningstagere
14 kontakter i FunnelfeedrJohn Crowley
Independent Director
Igor Mochalkin
Vice President of Discovery Technologies
Libuse Tauchmanova
Vice President of Global Clinical Development
Paul Scola
Senior Vice President of Chemistry
Jacques Moisan
Vice President of Biology & Translational Science
Steven Kelly
Chief Executive Officer and Director
Dimitrios Mantzilas
Chief Technology Officer & Site Head for Oslo Actithera AS
Berna Polack
Vice President of Global Clinical Affairs
Darshan Dalal
Chief Medical Officer
Torgeir Vaage
Acting Chief Financial Officer
Juergen Fleck
Vice President of Global Clinical Operations
Beatrice Brunkhorst
Head of Research & Development Operations and Program Management
Briggs Morrison
Chair of the Board
Hyelim Cho
Vice President Chief of Staff & Head of Strategy
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
NUCLITHERA AS
9 medarbejdereDeveloping targeted alpha and beta emitters for metastatic cancer treatment.
Tetrakit Technologies ApS
10 medarbejdereDeveloping innovative radiopharmaceuticals using advanced click chemistry for oncology.
SACRA Therapeutics AB
0 medarbejdereSACRA pioneers novel RNA-targeting therapies for incurable cancers.
CURASIGHT A/S
3 medarbejdereInnovative Danish biotech company developing targeted radiopharmaceutical cancer theranostics solutions.
Beactica Therapeutics AB
5 medarbejderePrecision medicine company developing novel therapeutics via targeted protein degradation.
Udforsk mere
Spørgsmål om ACTITHERA NORWAY AS
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo